368 related articles for article (PubMed ID: 17632098)
1. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
Momi S; Impagnatiello F; Guzzetta M; Caracchini R; Guglielmini G; Olivieri R; Monopoli A; Gresele P
Eur J Pharmacol; 2007 Sep; 570(1-3):115-24. PubMed ID: 17632098
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms.
Castro MM; Rizzi E; Rascado RR; Nagassaki S; Bendhack LM; Tanus-Santos JE
Eur J Pharmacol; 2004 Sep; 498(1-3):189-94. PubMed ID: 15363994
[TBL] [Abstract][Full Text] [Related]
3. Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.
Riad A; Du J; Stiehl S; Westermann D; Mohr Z; Sobirey M; Doehner W; Adams V; Pauschinger M; Schultheiss HP; Tschöpe C
Eur J Pharmacol; 2007 Aug; 569(3):204-11. PubMed ID: 17669395
[TBL] [Abstract][Full Text] [Related]
4. The nitric oxide-donating pravastatin derivative, NCX 6550 [(1S-[1alpha(betaS*, deltaS*), 2alpha, 6alpha, 8beta-(R*), 8a alpha]]-1,2,6,7,8,8a-Hexahydro-beta, delta, 6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphtalene-heptanoic acid 4-(nitrooxy)butyl ester)], reduces splenocyte adhesion and reactive oxygen species generation in normal and atherosclerotic mice.
Dever G; Spickett CM; Kennedy S; Rush C; Tennant G; Monopoli A; Wainwright CL
J Pharmacol Exp Ther; 2007 Jan; 320(1):419-26. PubMed ID: 17005918
[TBL] [Abstract][Full Text] [Related]
5. Modulation of iNOS expression by a nitric oxide-releasing derivative of the natural antioxidant ferulic acid in activated RAW 264.7 macrophages.
Ronchetti D; Impagnatiello F; Guzzetta M; Gasparini L; Borgatti M; Gambari R; Ongini E
Eur J Pharmacol; 2006 Feb; 532(1-2):162-9. PubMed ID: 16443213
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis.
Momi S; Monopoli A; Alberti PF; Falcinelli E; Corazzi T; Conti V; Miglietta D; Ongini E; Minuz P; Gresele P
Cardiovasc Res; 2012 Jun; 94(3):428-38. PubMed ID: 22362817
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
Wagner AH; Schwabe O; Hecker M
Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M
J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163
[TBL] [Abstract][Full Text] [Related]
9. A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury.
Wu WP; Hao JX; Ongini E; Impagnatiello F; Presotto C; Wiesenfeld-Hallin Z; Xu XJ
Br J Pharmacol; 2004 Jan; 141(1):65-74. PubMed ID: 14662726
[TBL] [Abstract][Full Text] [Related]
10. Suppression of inflammatory response and endothelial nitric oxide synthase downregulation in hyperlipidaemic C57BL/6J mice by eugenosedin-A.
Shen KP; Lin HL; Chang WT; An LM; Chen IJ; Wu BN
J Pharm Pharmacol; 2011 Jun; 63(6):860-8. PubMed ID: 21585385
[TBL] [Abstract][Full Text] [Related]
11. A nitric oxide-releasing salbutamol elicits potent relaxant and anti-inflammatory activities.
Lagente V; Naline E; Guenon I; Corbel M; Boichot E; Burgaud JL; Del Soldato P; Advenier C
J Pharmacol Exp Ther; 2004 Jul; 310(1):367-75. PubMed ID: 15084649
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects.
Tannous M; Cheung R; Vignini A; Mutus B
Thromb Haemost; 1999 Nov; 82(5):1390-4. PubMed ID: 10595624
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations.
Buccellati C; Sala A; Rossoni G; Capra V; Rovati GE; Di Gennaro A; Folco G; Colli S; Casagrande C
J Pharmacol Exp Ther; 2006 May; 317(2):830-7. PubMed ID: 16399881
[TBL] [Abstract][Full Text] [Related]
14. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
[TBL] [Abstract][Full Text] [Related]
15. Biphasic effects of atorvastatin on inflammation.
Garjani A; Andalib S; Ziaee M; Maleki-Dizaji N
Pak J Pharm Sci; 2008 Apr; 21(2):125-30. PubMed ID: 18390442
[TBL] [Abstract][Full Text] [Related]
16. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase-2, and proinflammatory cytokines expressions via nuclear factor-kappaB inactivation.
Yun KJ; Koh DJ; Kim SH; Park SJ; Ryu JH; Kim DG; Lee JY; Lee KT
J Agric Food Chem; 2008 Nov; 56(21):10265-72. PubMed ID: 18841975
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats.
Pannu R; Barbosa E; Singh AK; Singh I
J Neurosci Res; 2005 Feb; 79(3):340-50. PubMed ID: 15605375
[TBL] [Abstract][Full Text] [Related]
19. Lack of critical involvement of endothelial nitric oxide synthase in vascular nitrate tolerance in mice.
Wang EQ; Lee WI; Fung HL
Br J Pharmacol; 2002 Jan; 135(2):299-302. PubMed ID: 11815364
[TBL] [Abstract][Full Text] [Related]
20. Ramipril treatment protects against nitrate-induced oxidative stress in eNOS-/- mice: An implication of the NADPH oxidase pathway.
Otto A; Fontaine J; Berkenboom G
J Cardiovasc Pharmacol; 2006 Jul; 48(1):842-9. PubMed ID: 16891913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
